20-F: Origin Agritech Reports Increased Revenue and Net Income in Fiscal Year 2023

Origin Agritech's fiscal year 2023 saw a significant increase in revenue and a return to net income, driven by strong performance in its Xinjiang facility and new hybrid seed varieties.

Summary

• Origin Agritech Limited reported its fiscal year 2023 results, showing a notable increase in revenue to RMB 93.3 million (US$13 million) compared to RMB 52.6 million in the previous year.
• The revenue increase was attributed to the reopening of the Xinjiang facility and the successful market performance of new hybrid seed varieties.
• The company's total operating expenses increased slightly to RMB 32.2 million (US$4.5 million) from RMB 29.1 million in fiscal year 2022.
• Origin Agritech achieved a net income of RMB 62.7 million (US$8.7 million) in fiscal year 2023, a significant improvement from the net income of RMB 2.3 million in fiscal year 2022.
• Net income per share was RMB 8.45 (US$1.18) for fiscal year 2023, compared to a net loss per share of RMB 1.09 in the previous year.
• Total assets increased to RMB 238.5 million, compared to RMB 136 million in the previous year, due to the conversion of a controlled subsidiary into a long-term investment.
• The company's cash and cash equivalents stood at RMB 23.7 million (US$3.3 million) as of September 30, 2023.
• The company repaid borrowings from BC-TID and converted it to equity in 2023.
• Net cash provided by operating activities was RMB 5.5 million (US$0.76 million), compared to net cash used in operating activities of RMB 3.3 million in the previous year.
• The company raised $2.73 million from the sale of 320,000 ordinary shares during the fiscal year ended September 30, 2023.

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While there's positive news regarding increased revenue and net income, concerns about internal controls, VIE structure risks, and regulatory uncertainties temper the overall outlook.

Positives

• Significant increase in revenue and a return to net income.
• Successful reopening of the Xinjiang facility.
• Strong market performance of new hybrid seed varieties.
• The company is actively pursuing approval and commercialization of its biotech seed products and developing nutrition enhanced corn (NEC).
• Net cash provided by operating activities was RMB 5.5 million (US$0.76 million), compared to net cash used in operating activities of RMB 3.3 million in the previous year.

Negatives

• The company's disclosure controls and procedures as of September 30, 2023 were ineffective as management has identified a material weaknesses.
• The company has a working capital deficit of RMB 171.6 million as of September 30, 2023.
• The company has an accumulated deficit of RMB601.6 million as of September 30, 2023.

Risks

• The company's disclosure controls and procedures as of September 30, 2023 were ineffective as management has identified a material weaknesses.
• The company's future success depends on the successful development and commercialization of its biotech pipeline of products.
• The company faces potential uncertainty in government regulation in China regarding genetic technology and genetically modified agricultural products.
• The company faces significant international competition in the GM seed market.
• The company may be exposed to product quality claims.
• The company has limited business insurance coverage in China.
• The company operates a portion of its seed business through a VIE structure, which carries inherent risks.
• The company's consignment agreements and VIE arrangements have not been tested in the courts for their legality or enforceability.
• The company may lose the ability to use and enjoy assets held by the VIE if the VIE declares bankruptcy or becomes subject to a dissolution or liquidation proceeding.
• The oversight of the China Securities Regulatory Commission, Cyberspace Administration of China or other governmental authorities may adversely affect our business and their approval may be required in connection with this offering, and, if required, we cannot predict whether we will be able to obtain such approval.

Future Outlook

The company is actively pursuing approval and commercialization of its biotech seed products and developing nutrition enhanced corn (NEC).

Industry Context

The report reflects Origin Agritech's position within the evolving agricultural biotechnology sector in China, where there is increasing government support for GM crops but also regulatory uncertainty and competition from both domestic and international players.

Comparison to Industry Standards

• It's difficult to directly compare Origin Agritech's results to global industry standards without more specific information on their product portfolio and market share.
• Companies like Bayer (Monsanto) and Corteva Agriscience dominate the global GM seed market, particularly in corn, with extensive R&D resources and established market presence.
• Origin Agritech's focus on the Chinese market and its partnerships with local research institutes differentiate it from these global players.
• The company's success will depend on its ability to navigate the regulatory landscape in China and gain market acceptance for its GM seed products.

Corporate Governance

Legal Proceedings

• Origin Biotechnology is involved in a lawsuit with Henan Yingdafeng Agricultural Development Limited regarding a corn supply contract, with the case currently sent back to the People's Court of Neixiang County, Henan Province for retrial.

Related Party Transactions

• The company has significant transactions and account balances with related parties, including entities controlled by the close family members of the company's Chairman.
• These transactions include sales to and purchases from related parties, as well as cash advances to fund the company's operations.

Stakeholder Impact

• Shareholders: The increased revenue and net income are positive for shareholders, but risks related to the VIE structure and regulatory environment remain.
• Employees: The company's continued operations and research and development activities provide employment opportunities.
• Customers: The company's focus on developing new and improved seed varieties benefits farmers and agricultural producers.
• Suppliers: The company's purchases of raw materials from suppliers contribute to the agricultural supply chain.

Next Steps

• The company is actively pursuing approval and commercialization of its biotech seed products.
• The company is making increasing efforts in the development of nutrition enhanced corn (NEC).
• The company is cooperating with the Institute of Biotechnology of the Chinese Academy of Agricultural Sciences to promote the safety declaration of drought resistant transgenic corn event NAZ 4.
• The company is integrating the insect resistant and herbicide tolerant corn inbred line and completed seed production in Sanya, Hainan in the winter of 2022.
• The company is integrating the traits of insect resistance and herbicide tolerance of the three events into corn inbred lines of Origin by using backcross breeding technology and molecular marker technology.

Key Dates

Keywords

Origin Agritech, revenue, net income, GM seeds, biotechnology, China, seed, agriculture, Xinjiang, hybrid, corn, VIE, financial results